Last reviewed · How we verify
NCT03276390: HKTP
A Culturally Targeted Transplant Program
NA trial testing Hispanic Kidney Transplant Program (HKTP) in ESRD in 11,836 participants. Completed in 28 February 2021.
28 February 2021
Quick facts
| Lead sponsor | Northwestern University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | health services research |
| Enrollment | 11,836 |
| Start date | 18 January 2017 |
| Primary completion | 28 February 2021 |
| Estimated completion | 28 February 2021 |
| Sites | 4 locations across United States |
Drugs / interventions tested
- Hispanic Kidney Transplant Program (HKTP)
Conditions studied
- ESRD — all drugs for ESRD →
Sponsor
Northwestern University
Who can join
Adults 18 to 100, any sex, with ESRD. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Hispanic/Latino patients with end-stage renal disease are disproportionately less likely to get a kidney transplant, and specifically, a living donor kidney transplant (LDKT), compared to non-Hispanic whites. Accordingly, without LDKTs, Hispanics experience longer transplant waiting times, shorter patient and graft survival, and worse quality of life. Cultural beliefs and linguistic barriers contribute to the disparity in LDKTs. The objective of the proposed study is to implement and evaluate Northwestern Medicine's® Hispanic Kidney Transplant Program, a culturally-competent transplant center-based intervention, at two transplant centers serving large Hispanic populations. The proposed study will provide valuable knowledge about the potential to rapidly disseminate the HKTP as a novel approach to increase Hispanic LDKTs nationally.
Publications & conference data
8 peer-reviewed publications reference this trial (live from Europe PMC):
-
Effectiveness of a culturally competent care intervention in reducing disparities in Hispanic live donor kidney transplantation: A hybrid trial.
Gordon EJ, Uriarte JJ, Lee J, Kang R, et al · · 2022 · cited 33× · PMID 34559944 · DOI 10.1111/ajt.16857 -
A complex culturally targeted intervention to reduce Hispanic disparities in living kidney donor transplantation: an effectiveness-implementation hybrid study protocol.
Gordon EJ, Lee J, Kang RH, Caicedo JC, et al · · 2018 · cited 33× · PMID 29769080 · DOI 10.1186/s12913-018-3151-5 -
Implementing culturally competent transplant care and implications for reducing health disparities: A prospective qualitative study.
Gordon EJ, Romo E, Amórtegui D, Rodas A, et al · · 2020 · cited 23× · PMID 33037746 · DOI 10.1111/hex.13124 -
Disparities Persist Among Hispanic Patients: Completing Evaluation, Waitlisting, and Receiving a Kidney Transplant.
Gordon EJ, Lee J, Kang R, Uriarte J, et al · · 2024 · cited 11× · PMID 38414978 · DOI 10.1097/txd.0000000000001595 -
Financial Feasibility Analysis of a Culturally and Linguistically Competent Hispanic Kidney Transplant Program.
Wang A, Caicedo JC, McNatt G, Abecassis M, et al · · 2021 · cited 10× · PMID 32282660 · DOI 10.1097/tp.0000000000003269 -
Patients' perceptions of a culturally targeted Hispanic Kidney Transplant Program: A mixed methods study.
Alhalel N, Francone NO, Salazar AM, Primeaux S, et al · · 2019 · cited 8× · PMID 31034642 · DOI 10.1111/ctr.13577 -
Financial Impact of a Culturally Sensitive Hispanic Kidney Transplant Program on Increasing Living Donation.
Wang A, Caicedo JC, Mathur AK, Ruiz RM, et al · · 2023 · cited 7× · PMID 36346212 · DOI 10.1097/tp.0000000000004382 -
Implementation and modification of an organizational-level intervention: a prospective analysis.
Gordon EJ, Uriarte JJ, Anderson N, Romo E, et al · · 2022 · cited 6× · PMID 35659156 · DOI 10.1186/s43058-022-00296-0
Verify or expand the search:
- PubMed search for NCT03276390
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for ESRD
Currently open trials in the same condition.
- NCT06913647 — Effect of Canagliflozin on Ultrafiltration & Fibrosis in Patients on Peritoneal Dialysis · Phase 2 · recruiting
- NCT06366230 — Adding Urea to the Final Dialysis Fluid · Phase 1, PHASE2 · recruiting
- NCT05339139 — SAfety of Regional Citrate Anticoagulation (SARCA Study) · Phase 3 · recruiting
- NCT05434325 — TESTING -ON Post-Trial ObservatioNal Cohort Study · recruiting
- NCT05309785 — Safety and Efficacy of Canagliflozin in Advanced CKD · Phase 4 · active not recruiting
Other Northwestern University trials
Trials by the same sponsor.
- NCT06545695 — Epidermal Growth Factor Receptor Inhibition for Keratinopathies · Phase 1, PHASE2 · not yet recruiting
- NCT07261657 — N-803 in Patients With Progressive Synovial Sarcoma and Myxoid/Round Cell Liposarcoma Previously Treated With Adoptive C · EARLY_PHASE1 · not yet recruiting
- NCT07392775 — ALDH2 Genetic Testing in East Asian Community · NA · not yet recruiting
- NCT06886776 — Implementing A Secure Firearm Storage Program in Illinois Health Centers in Partnership With AllianceChicago and the Ill · NA · not yet recruiting
- NCT07469176 — Co-Designing and Evaluating Additional Mothers and Babies Program Content for Expectant and New Parents of Children With · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03276390 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Northwestern University
- Last refreshed: 3 October 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03276390.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing